Cargando…

Single-agent FOXO1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice

OBJECTIVES: Insulin treatment remains the sole effective intervention for Type 1 Diabetes. Here, we investigated the therapeutic potential of converting intestinal epithelial cells to insulin-producing, glucose-responsive β-like cells by targeted inhibition of FOXO1. We have previously shown that th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yun-Kyoung, Du, Wen, Nie, Yaohui, Diaz, Bryan, Sultana, Nishat, Kitamoto, Takumi, Leibel, Rudolph L., Accili, Domenico, Belvedere, Sandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676376/ https://www.ncbi.nlm.nih.gov/pubmed/36283677 http://dx.doi.org/10.1016/j.molmet.2022.101618

Ejemplares similares

Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes
por: Kitamoto, Takumi, et al.
Publicado: (2022)

FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice
por: Lee, Yun-Kyoung, et al.
Publicado: (2021)

Pharmacological conversion of gut epithelial cells into insulin-producing cells lowers glycemia in diabetic animals
por: Du, Wen, et al.
Publicado: (2022)

FOXO1 Inhibition Yields Functional Insulin-Producing Cells In Human Gut Organoid Cultures
por: Bouchi, Ryotaro, et al.
Publicado: (2014)

FOXO1 Is Present in Stomach Epithelium and Determines Gastric Cell Distribution
por: McKimpson, Wendy M., et al.
Publicado: (2022)

SUN-646 A Novel Population of FOXO1-Expressing Cells in the Stomach Controls Cell Plasticity by Regulating the Cyclin CCNE1
por: McKimpson, Wendy M, et al.
Publicado: (2020)

Generation Of Functional Insulin-Producing Cells In The Gut By Foxo1 Ablation
por: Talchai, Chutima, et al.
Publicado: (2012)

Cyb5r3 links FoxO1-dependent mitochondrial dysfunction with β-cell failure
por: Fan, Jason, et al.
Publicado: (2020)

Legacy Effect of Foxo1 in Pancreatic Endocrine Progenitors on Adult β-Cell Mass and Function
por: Talchai, Shivatra Chutima, et al.
Publicado: (2015)

Preserved Energy Balance in Mice Lacking FoxO1 in Neurons of Nkx2.1 Lineage Reveals Functional Heterogeneity of FoxO1 Signaling Within the Hypothalamus
por: Heinrich, Garrett, et al.
Publicado: (2014)

InsR/FoxO1 Signaling Curtails Hypothalamic POMC Neuron Number
por: Plum, Leona, et al.
Publicado: (2012)

Effects of Dietary Supplementation with Agaricus sylvaticus Schaeffer on Glycemia and Cholesterol after Streptozotocin-Induced Diabetes in Rats
por: Mascaro, Marcelo Betti, et al.
Publicado: (2014)

Bixin and Norbixin Have Opposite Effects on Glycemia, Lipidemia, and Oxidative Stress in Streptozotocin-Induced Diabetic Rats
por: Roehrs, Miguel, et al.
Publicado: (2014)

Regulation of insulin-like growth factor–dependent myoblast differentiation by Foxo forkhead transcription factors
por: Hribal, Marta L., et al.
Publicado: (2003)

Patterns of Glycemia in Normal Pregnancy: Should the current therapeutic targets be challenged?
por: Hernandez, Teri L., et al.
Publicado: (2011)

microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function
por: Langlet, Fanny, et al.
Publicado: (2018)

A Mutant Allele Encoding DNA Binding–Deficient FoxO1 Differentially Regulates Hepatic Glucose and Lipid Metabolism
por: Cook, Joshua R., et al.
Publicado: (2015)

Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1–dependent manner
por: Pajvani, Utpal B., et al.
Publicado: (2011)

FoxO Feedback Control of Basal IRS-2 Expression in Pancreatic β-Cells Is Distinct From That in Hepatocytes
por: Tsunekawa, Shin, et al.
Publicado: (2011)

Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell function
por: Kuo, Taiyi, et al.
Publicado: (2021)

Diabetes Treatment and Measures of Glycemia
por: Bloomgarden, Zachary T.
Publicado: (2009)

COVID-19, colchicine and glycemia
por: Ilias, Ioannis, et al.
Publicado: (2021)

Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models
por: Liang, Yin, et al.
Publicado: (2012)

Type 2 Diabetes Prevention Focused on Normalization of Glycemia: A Two-Year Pilot Study
por: McKenzie, Amy L, et al.
Publicado: (2021)

Foxo1 Links Hyperglycemia to LDL Oxidation and Endothelial Nitric Oxide Synthase Dysfunction in Vascular Endothelial Cells
por: Tanaka, Jun, et al.
Publicado: (2009)

ACCORD Glycemia Results Continue to Puzzle
por: Boyko, Edward J.
Publicado: (2010)

Management of Glycemia in Acute Febrile Illness
por: Kalra, Sanjay, et al.
Publicado: (2017)

Assessment of glycemia in chronic kidney disease
por: Hassanein, Mohamed, et al.
Publicado: (2022)

Hepatic FoxO1 Integrates Glucose Utilization and Lipid Synthesis through Regulation of Chrebp O-Glycosylation
por: Ido-Kitamura, Yukari, et al.
Publicado: (2012)

GLUT4-overexpressing engineered muscle constructs as a therapeutic platform to normalize glycemia in diabetic mice
por: Beckerman, Margarita, et al.
Publicado: (2021)

Blunted Refeeding Response and Increased Locomotor Activity in Mice Lacking FoxO1 in Synapsin-Cre–Expressing Neurons
por: Ren, Hongxia, et al.
Publicado: (2013)

Integrated Control Of Hepatic Lipogenesis Vs. Glucose Production Requires FoxO Transcription Factors
por: Haeusler, Rebecca A., et al.
Publicado: (2014)

Acute Effects of Dietary Carbohydrate Restriction on Glycemia, Lipemia and Appetite Regulating Hormones in Normal-Weight to Obese Subjects
por: Samkani, Amirsalar, et al.
Publicado: (2018)

Soluble Suppression of Tumorigenicity 2 is Directly Correlated with Glycated Hemoglobin in Individuals with an Average glycemia in the Normal/Prediabetes Range
por: Hasan, Amal, et al.
Publicado: (2020)

Nontraditional Markers of Glycemia: Associations with microvascular conditions
por: Selvin, Elizabeth, et al.
Publicado: (2011)

Drug-drug Interaction-related Uncontrolled Glycemia
por: Hammad, Mohamed Anwar, et al.
Publicado: (2017)

Dopaminergic Control of Inflammation and Glycemia in Sepsis and Diabetes
por: Feketeova, Eleonora, et al.
Publicado: (2018)

Maternal BMI and Glycemia Impact the Fetal Metabolome
por: Lowe, William L., et al.
Publicado: (2017)

Amelioration of streptozotocin-induced pancreatic β cell damage by morin: Involvement of the AMPK-FOXO3-catalase signaling pathway
por: Wang, Ning, et al.
Publicado: (2018)

Keratinocyte Function in Normal and Diabetic Wounds and Modulation by FOXO1
por: Wang, Yulan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4i8ddsll3d3jsds321e0lmapm9